深圳市海普瑞药业集团股份有限公司-k8凯发国际娱乐大厅

language

k8凯发国际娱乐大厅 k8凯发国际娱乐大厅 english

about

company profile

chairman's remarks

development history

management team

corporate culture

established in 1998 in shenzhen, china, hepalink adheres to the grand vision of "bringing hope to patients, and creating value for clients".
science & innovation

scientific methodology

scientific committee

global r&d

pipeline

the two co-founders of hepalink are both senior experts in biosaccharide chemistry, and have in-depth understanding of the significant role of biosaccharide chemistry in immunoregulation. immunological imbalances are the leading cause of cardiovascular disease and tumor formation, and the clinical demand for these two major diseases are left unmet.
products & services

haparin industry chain

cdmo services

production sites

quality management

after years of hard work, hepalink has built a complete heparin industrial chain, which has become a healthy business portfolio that helps millions of global patients every year and creates steadily growing value for investors.
news

company news

media coverage
investors

szse disclosure

hkex disclosure

contact us
career

group station

en

k8凯发国际娱乐大厅 k8凯发国际娱乐大厅 english

home > investors > hkex disclosure > listing documents

listing documents

24 2020.06

yellow application form

learn more

2020-06-24
24 2020.06

white application form

learn more

2020-06-24
24 2020.06

green application form

learn more

2020-06-24
24 2020.06

global offering[announcements and notices]

learn more

2020-06-24
24 2020.06

global offering

learn more

2020-06-24

1

sitemap legal statement

© 2020 hepalink group all rights reserved.